pneumonia. Bacterial pneumonia, unspecified
Conditions
Interventions
Intervention 1: All patients in control group will receive enteral capsules of placebo (1 capsule/12h) for one week in addition to standard VAP treatment. Intervention 2: All patients in intervention
Placebo
Treatment - Drugs
All patients in control group will receive enteral capsules of placebo (1 capsule/12h) for one week in addition to standard VAP treatment.
All patients in intervention group will receive enteral capsules of Lactocare (1 capsule/12h) for one week in addition to standard VAP treatment.
Sponsors
Research deputy of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion: patients aging more than 18 years old and needing mechanical ventilation for a period of more than 48 hours Exclusion: History of pneumonia; dissatisfaction
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ventilator Associated Pneumonia. Timepoint: 7 days. Method of measurement: Assay with Clinically infectious pulmonary score and bronchoscopy. | — |
Secondary
| Measure | Time frame |
|---|---|
| ICU length of stay. Timepoint: during ICU stay. Method of measurement: days that patient is stayed in ICU. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAta Mahmoodpoor
Anesthesiology department, Tabriz University of Medical Sciences
Outcome results
None listed